{"brief_title": "Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer", "brief_summary": "The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.", "condition": "Carcinoma, Non-small-cell Lung", "intervention_type": "Drug", "intervention_name": "TLK286", "criteria": "Inclusion Criteria: - Histologic or cytologic diagnosis of non-small cell lung carcinoma - Progressed while on or after treatment on platinum-based regimen - Patients may not have had more than one prior cytotoxic chemotherapy regimen - Stage IV or IIIB - Age at least 18 years - Adequate liver and kidney function - Adequate bone marrow function Exclusion Criteria: - Pregnancy or lactation - Unstable medical conditions - Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy within 3 weeks of TLK286 - CNS metastasis unless controlled by treatment", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00040638.xml"}